SEC Form 4 · accession 0001209191-16-123425
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Alan Goldberg
Director
Period of report
May 24, 2016
Accepted (ET)
May 26, 2016 · 11:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.33 | May 24, 2016 | A | 18,000 | A | — | May 24, 2026 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable on the earlier of (i) May 24, 2017 or (ii) the date of the 2017 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.